HEADER TRANSFERASE 16-JAN-15 4XOY TITLE CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 8-358; COMPND 5 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 6 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 7 MAPK 2; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: MAPK1, ERK2, MAPK, PRKM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.GELIN,F.ALLEMAND,G.LABESSE,J.F.GUICHOU REVDAT 5 23-OCT-24 4XOY 1 REMARK REVDAT 4 10-JAN-24 4XOY 1 REMARK REVDAT 3 06-SEP-17 4XOY 1 REMARK SITE ATOM REVDAT 2 19-AUG-15 4XOY 1 JRNL REVDAT 1 12-AUG-15 4XOY 0 JRNL AUTH M.GELIN,V.DELFOSSE,F.ALLEMAND,F.HOH,Y.SALLAZ-DAMAZ, JRNL AUTH 2 M.PIROCCHI,W.BOURGUET,J.L.FERRER,G.LABESSE,J.F.GUICHOU JRNL TITL COMBINING `DRY' CO-CRYSTALLIZATION AND IN SITU DIFFRACTION JRNL TITL 2 TO FACILITATE LIGAND SCREENING BY X-RAY CRYSTALLOGRAPHY. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 71 1777 2015 JRNL REFN ESSN 1399-0047 JRNL PMID 26249358 JRNL DOI 10.1107/S1399004715010342 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.880 REMARK 3 COMPLETENESS FOR RANGE (%) : 78.6 REMARK 3 NUMBER OF REFLECTIONS : 36039 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.460 REMARK 3 FREE R VALUE TEST SET COUNT : 3411 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.2897 - 6.0405 0.75 1292 137 0.1939 0.2364 REMARK 3 2 6.0405 - 4.8014 0.79 1376 146 0.1752 0.1956 REMARK 3 3 4.8014 - 4.1964 0.80 1414 134 0.1471 0.1772 REMARK 3 4 4.1964 - 3.8136 0.81 1391 141 0.1467 0.1508 REMARK 3 5 3.8136 - 3.5408 0.80 1395 156 0.1572 0.1954 REMARK 3 6 3.5408 - 3.3323 0.81 1402 134 0.1677 0.2218 REMARK 3 7 3.3323 - 3.1657 0.82 1457 148 0.1764 0.2317 REMARK 3 8 3.1657 - 3.0280 0.82 1369 155 0.1792 0.2164 REMARK 3 9 3.0280 - 2.9115 0.82 1415 147 0.1866 0.2413 REMARK 3 10 2.9115 - 2.8112 0.82 1414 162 0.1824 0.2170 REMARK 3 11 2.8112 - 2.7233 0.82 1432 142 0.1869 0.2154 REMARK 3 12 2.7233 - 2.6455 0.83 1442 133 0.1845 0.2453 REMARK 3 13 2.6455 - 2.5759 0.83 1431 159 0.1797 0.2606 REMARK 3 14 2.5759 - 2.5131 0.83 1434 165 0.1829 0.2321 REMARK 3 15 2.5131 - 2.4560 0.84 1386 162 0.1804 0.2191 REMARK 3 16 2.4560 - 2.4038 0.83 1454 145 0.1881 0.2271 REMARK 3 17 2.4038 - 2.3557 0.85 1433 168 0.1906 0.2410 REMARK 3 18 2.3557 - 2.3113 0.83 1475 136 0.1908 0.2518 REMARK 3 19 2.3113 - 2.2700 0.85 1457 152 0.1993 0.2639 REMARK 3 20 2.2700 - 2.2315 0.83 1397 160 0.2059 0.2877 REMARK 3 21 2.2315 - 2.1956 0.83 1504 145 0.2104 0.2785 REMARK 3 22 2.1956 - 2.1618 0.55 942 93 0.2412 0.2746 REMARK 3 23 2.1618 - 2.1300 0.56 970 85 0.2558 0.2872 REMARK 3 24 2.1300 - 2.1000 0.55 946 106 0.2794 0.2962 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.670 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2785 REMARK 3 ANGLE : 1.124 3767 REMARK 3 CHIRALITY : 0.043 415 REMARK 3 PLANARITY : 0.006 477 REMARK 3 DIHEDRAL : 14.976 1048 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 9 THROUGH 120 ) REMARK 3 ORIGIN FOR THE GROUP (A): -15.0987 12.4248 35.7518 REMARK 3 T TENSOR REMARK 3 T11: 0.0814 T22: 0.1244 REMARK 3 T33: -0.1000 T12: 0.0148 REMARK 3 T13: -0.0352 T23: 0.0773 REMARK 3 L TENSOR REMARK 3 L11: 0.0019 L22: -0.0003 REMARK 3 L33: 0.0033 L12: -0.0074 REMARK 3 L13: 0.0028 L23: -0.0005 REMARK 3 S TENSOR REMARK 3 S11: -0.0079 S12: -0.0394 S13: 0.0458 REMARK 3 S21: -0.0151 S22: 0.0541 S23: 0.0780 REMARK 3 S31: -0.0222 S32: -0.0580 S33: -0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 121 THROUGH 353 ) REMARK 3 ORIGIN FOR THE GROUP (A): -0.2576 6.5204 55.2666 REMARK 3 T TENSOR REMARK 3 T11: 0.0501 T22: 0.0490 REMARK 3 T33: 0.0675 T12: -0.0024 REMARK 3 T13: 0.0021 T23: 0.0075 REMARK 3 L TENSOR REMARK 3 L11: 0.0313 L22: 0.0503 REMARK 3 L33: 0.0263 L12: 0.0108 REMARK 3 L13: 0.0123 L23: -0.0128 REMARK 3 S TENSOR REMARK 3 S11: 0.0036 S12: 0.0026 S13: 0.0441 REMARK 3 S21: 0.0022 S22: 0.0015 S23: 0.0088 REMARK 3 S31: 0.0220 S32: 0.0094 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XOY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JAN-15. REMARK 100 THE DEPOSITION ID IS D_1000206048. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97922 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28103 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 29.305 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.8 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.950 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: ISOMORPHOUS REPLACEMENT WITH A SIMPLE RIGID BODY REMARK 200 WITH REFMAC5, USING ANOTHER STRUCTURE OF THE SAME PROTEINE (3QYW) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% PEG MME 2000, 0.1M MES PH 6.5, REMARK 280 0.1M AMMONIUM SULFATE, 0.02M BETA-MERCAPTOETHANOL, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.70850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 8 REMARK 465 PRO A 56 REMARK 465 PHE A 57 REMARK 465 GLU A 58 REMARK 465 HIS A 59 REMARK 465 GLN A 60 REMARK 465 GLU A 184 REMARK 465 TYR A 185 REMARK 465 VAL A 186 REMARK 465 LYS A 328 REMARK 465 PHE A 329 REMARK 465 ASP A 330 REMARK 465 MET A 331 REMARK 465 GLU A 332 REMARK 465 LEU A 333 REMARK 465 ASP A 334 REMARK 465 PRO A 354 REMARK 465 GLY A 355 REMARK 465 TYR A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 61 OG1 CG2 REMARK 470 LYS A 229 CG CD CE NZ REMARK 470 ASP A 335 CB CG OD1 OD2 REMARK 470 LYS A 340 CG CD CE NZ REMARK 470 GLU A 347 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 303 O HOH A 501 2.00 REMARK 500 OG1 THR A 183 O HOH A 502 2.07 REMARK 500 OH TYR A 315 O HOH A 503 2.13 REMARK 500 O ALA A 33 O HOH A 504 2.14 REMARK 500 NH1 ARG A 65 O HOH A 505 2.17 REMARK 500 OD2 ASP A 249 O HOH A 506 2.17 REMARK 500 O HOH A 507 O HOH A 631 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 17 75.49 -118.36 REMARK 500 TYR A 34 -42.55 84.80 REMARK 500 ASN A 45 39.27 -143.93 REMARK 500 LYS A 97 -70.91 -119.31 REMARK 500 ARG A 146 -1.71 76.38 REMARK 500 ASP A 147 41.50 -141.90 REMARK 500 ASP A 165 87.56 67.24 REMARK 500 ASP A 173 73.51 -153.86 REMARK 500 ASN A 199 20.76 -154.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 642 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH A 643 DISTANCE = 6.61 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DX4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 DBREF 4XOY A 8 358 UNP P63086 MK01_RAT 8 358 SEQRES 1 A 351 GLY PRO GLU MET VAL ARG GLY GLN VAL PHE ASP VAL GLY SEQRES 2 A 351 PRO ARG TYR THR ASN LEU SER TYR ILE GLY GLU GLY ALA SEQRES 3 A 351 TYR GLY MET VAL CYS SER ALA TYR ASP ASN LEU ASN LYS SEQRES 4 A 351 VAL ARG VAL ALA ILE LYS LYS ILE SER PRO PHE GLU HIS SEQRES 5 A 351 GLN THR TYR CYS GLN ARG THR LEU ARG GLU ILE LYS ILE SEQRES 6 A 351 LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY ILE ASN SEQRES 7 A 351 ASP ILE ILE ARG ALA PRO THR ILE GLU GLN MET LYS ASP SEQRES 8 A 351 VAL TYR ILE VAL GLN ASP LEU MET GLU THR ASP LEU TYR SEQRES 9 A 351 LYS LEU LEU LYS THR GLN HIS LEU SER ASN ASP HIS ILE SEQRES 10 A 351 CME TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU LYS TYR SEQRES 11 A 351 ILE HIS SER ALA ASN VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 12 A 351 SER ASN LEU LEU LEU ASN THR THR CME ASP LEU LYS ILE SEQRES 13 A 351 CME ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO ASP HIS SEQRES 14 A 351 ASP HIS THR GLY PHE LEU THR GLU TYR VAL ALA THR ARG SEQRES 15 A 351 TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SER LYS GLY SEQRES 16 A 351 TYR THR LYS SER ILE ASP ILE TRP SER VAL GLY CYS ILE SEQRES 17 A 351 LEU ALA GLU MET LEU SER ASN ARG PRO ILE PHE PRO GLY SEQRES 18 A 351 LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU GLY ILE SEQRES 19 A 351 LEU GLY SER PRO SER GLN GLU ASP LEU ASN CME ILE ILE SEQRES 20 A 351 ASN LEU LYS ALA ARG ASN TYR LEU LEU SER LEU PRO HIS SEQRES 21 A 351 LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO ASN ALA SEQRES 22 A 351 ASP SER LYS ALA LEU ASP LEU LEU ASP LYS MET LEU THR SEQRES 23 A 351 PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN ALA LEU SEQRES 24 A 351 ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SER ASP SEQRES 25 A 351 GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP MET GLU SEQRES 26 A 351 LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU LEU ILE SEQRES 27 A 351 PHE GLU GLU THR ALA ARG PHE GLN PRO GLY TYR ARG SER MODRES 4XOY CME A 125 CYS MODIFIED RESIDUE MODRES 4XOY CME A 159 CYS MODIFIED RESIDUE MODRES 4XOY CME A 164 CYS MODIFIED RESIDUE MODRES 4XOY CME A 252 CYS MODIFIED RESIDUE HET CME A 125 10 HET CME A 159 10 HET CME A 164 10 HET CME A 252 10 HET DX4 A 401 11 HET SO4 A 402 5 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM DX4 2-AMINO-1,9-DIHYDRO-6H-PURINE-6-THIONE HETNAM SO4 SULFATE ION FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 2 DX4 C5 H5 N5 S FORMUL 3 SO4 O4 S 2- FORMUL 4 HOH *143(H2 O) HELIX 1 AA1 TYR A 62 PHE A 76 1 15 HELIX 2 AA2 LEU A 110 GLN A 117 1 8 HELIX 3 AA3 SER A 120 ALA A 141 1 22 HELIX 4 AA4 LYS A 149 SER A 151 5 3 HELIX 5 AA5 ASP A 173 ASP A 177 5 5 HELIX 6 AA6 THR A 188 ARG A 192 5 5 HELIX 7 AA7 ALA A 193 ASN A 199 1 7 HELIX 8 AA8 LYS A 205 ASN A 222 1 18 HELIX 9 AA9 HIS A 230 GLY A 243 1 14 HELIX 10 AB1 SER A 246 CME A 252 1 7 HELIX 11 AB2 ASN A 255 LEU A 265 1 11 HELIX 12 AB3 PRO A 272 PHE A 277 1 6 HELIX 13 AB4 ASP A 281 LEU A 292 1 12 HELIX 14 AB5 GLU A 301 ALA A 307 1 7 HELIX 15 AB6 HIS A 308 GLU A 312 5 5 HELIX 16 AB7 ASP A 316 GLU A 320 5 5 HELIX 17 AB8 PRO A 337 THR A 349 1 13 HELIX 18 AB9 ALA A 350 GLN A 353 5 4 SHEET 1 AA1 5 TYR A 23 GLU A 31 0 SHEET 2 AA1 5 MET A 36 ASP A 42 -1 O VAL A 37 N GLY A 30 SHEET 3 AA1 5 VAL A 47 ILE A 54 -1 O ILE A 51 N CYS A 38 SHEET 4 AA1 5 VAL A 99 ASP A 104 -1 O GLN A 103 N ALA A 50 SHEET 5 AA1 5 ASP A 86 ILE A 88 -1 N ASP A 86 O VAL A 102 SHEET 1 AA2 3 THR A 108 ASP A 109 0 SHEET 2 AA2 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 AA2 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 AA3 2 VAL A 143 LEU A 144 0 SHEET 2 AA3 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 LINK C ILE A 124 N CME A 125 1555 1555 1.33 LINK C CME A 125 N TYR A 126 1555 1555 1.34 LINK C THR A 158 N CME A 159 1555 1555 1.33 LINK C CME A 159 N ASP A 160 1555 1555 1.33 LINK C ILE A 163 N CME A 164 1555 1555 1.33 LINK C CME A 164 N ASP A 165 1555 1555 1.33 LINK C ASN A 251 N CME A 252 1555 1555 1.33 LINK C CME A 252 N ILE A 253 1555 1555 1.32 SITE 1 AC1 6 ALA A 50 LYS A 52 GLN A 103 ASP A 104 SITE 2 AC1 6 MET A 106 CME A 164 SITE 1 AC2 4 ARG A 189 ARG A 192 TYR A 231 HOH A 518 CRYST1 49.178 71.417 61.263 90.00 109.51 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020334 0.000000 0.007205 0.00000 SCALE2 0.000000 0.014002 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017317 0.00000